Actor and comedian Pat Finn, known for roles in 'The Middle,' 'Friends,' and 'Seinfeld,' died at age 60 after a three-year battle with bladder cancer. He was also known for his work in improv, TV roles, and films, and is survived by his family.
Pat Finn, an actor known for his role as Dr. Roger on 'Friends' and appearances on various TV shows, died at age 60 after battling bladder cancer for three years. He was remembered as a joyful and kind person by his family and friends.
Merck announced positive results from the Phase 3 KEYNOTE-B15 trial showing that combining KEYTRUDA (pembrolizumab) with Padcev (enfortumab vedotin) before and after surgery significantly improves survival and response rates in cisplatin-eligible muscle-invasive bladder cancer patients, with a safety profile consistent with known effects.
D’Wayne Wiggins, a key member of Tony! Toni! Toné!, was celebrated for his contributions to R&B and his deep roots in Oakland's community and music scene, passing away from bladder cancer after a life dedicated to music and connection.
A new implant called TAR-200 has shown promising results in a phase 2 trial, eliminating tumors in 82% of high-risk bladder cancer patients resistant to previous treatments, with most tumors disappearing within three months and many patients remaining cancer-free after a year, offering a potentially safer and more effective alternative to traditional therapies.
Pharma companies Pfizer, Merck, and Astellas reported promising results from a study showing that their drug combination of Padcev and Keytruda significantly extends survival and reduces recurrence in muscle-invasive bladder cancer patients, offering new hope for treatment options.
The FDA has approved INLEXZO™, a new intravesical system for treating certain bladder cancers, offering a bladder-preserving option for patients unresponsive to BCG therapy, with promising clinical trial results showing high response rates and manageable safety profile.
Colorado's football team introduced a branded sideline bathroom sponsored by Depend for coach Deion Sanders, who recently underwent bladder cancer treatment and needs frequent restroom access, highlighting a unique blend of health awareness and marketing in college sports.
A new bladder cancer treatment using the TAR-200 device, which delivers chemotherapy directly into the bladder, has shown promising results with 82% of patients experiencing cancer disappearance after three months, and nearly half remaining cancer-free after a year, representing a significant breakthrough in treatment options.
A new pretzel-shaped implant called TAR-200, containing chemotherapy drug gemcitabine, has shown promising results in eradicating bladder cancer in over 80% of patients, especially those with carcinoma in situ, by releasing the drug steadily over three weeks. The device, which is less invasive than surgery, has demonstrated higher response rates than existing treatments and is currently under FDA review, potentially revolutionizing bladder cancer therapy.
A new slow-release drug system called TAR-200 has shown to eliminate bladder cancer in 82% of patients in a clinical trial, especially effective for those unresponsive to traditional therapies, with the potential for FDA approval and improved quality of life for patients.
Deion Sanders, the head coach of the University of Colorado, underwent a successful neobladder reconstruction surgery to treat bladder cancer, using tissue from his small intestine to create a new bladder, which he publicly discussed to raise awareness about the disease and the surgical process.
Deion Sanders' recent bladder cancer surgery highlights the importance of early detection and raises awareness about health disparities affecting Black communities, emphasizing the need for accessible preventative screenings and lifestyle changes to combat higher cancer risks.
Deion Sanders, the University of Colorado football coach and NFL Hall of Famer, publicly revealed he underwent bladder removal surgery after being diagnosed with an aggressive form of bladder cancer.
Deion Sanders, the Colorado coach and Hall of Famer, announced he has beaten bladder cancer and has partnered with Depend to promote awareness, resilience, and reduce stigma around health issues, inspiring others to face health challenges with courage.